Explore the risks and precautions for diabetics using supplements like Vitamin E, St. John's Wort, Ginseng, Niacin, and Chromium, which can affect blood sugar levels and...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
39 readers recommended
Cannabis use in people with type 1 diabetes can raise DKA risk and trigger a condition with similar symptoms called HK-CHS. Monitoring glucose, understanding effects,...
1,209 readers recommended
Starting on metformin? My journey with type 2 diabetes on learning how to deal with side effects, “faux lows,” and learning more about this therapy.
149 readers recommended
This article details Mounjaro's efficacy in type 2 diabetes management, highlighting the drug’s ability to significantly reduce A1C and body weight. Read about the...
36 readers recommended
Discover advancements in diabetic macular edema treatment options, including anti-VEGF therapies and non-invasive drugs, for better management of this vision-threatening...
47 readers recommended
Led by Dr. Jeremy Pettus, researchers at UC San Diego are investigating liver-targeted insulin in type 1 diabetes. Explore how this novel insulin could significantly...
23 readers recommended
People with diabetes are at higher risk for health issues like chronic kidney disease, diabetic macular edema, and liver disease. Here are clinical trials studying ways...
17 readers recommended
Orforglipron, Eli Lilly's once-daily oral GLP-1 receptor agonist, is being studied in ongoing clinical trials for obesity and type 2 diabetes. Data shows A1C reductions...
75 readers recommended
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can...
16 readers recommended
The FINE-ONE trial by Bayer investigates Kerendia's effectiveness in preventing kidney disease progression in people with type 1 diabetes. This pivotal trial could...
41 readers recommended
Novo Nordisk is set to discontinue Levemir, a key long-acting insulin, by the end of 2024 due to manufacturing priorities and better alternatives, impacting supply and...
32 readers recommended
FDA approves Zepbound for obesity management alongside diet and exercise. A promising new option for weight control, it's the second once-weekly injectable after Wegovy...
21 readers recommended
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
18 readers recommended
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
40 readers recommended
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
104 readers recommended
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
34 readers recommended
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
60 readers recommended
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
45 readers recommended
People with type 1 diabetes face higher kidney risks, yet treatments approved for type 2 aren't FDA approved for them due to clinical trial gaps. The EASD 2023 panel...
41 readers recommended
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...